HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

503.398

-20.475-3.91%

Number of Gainers:8

Number of Losers:24

Number of Flat:1

PE:- -

High:523.582

Open:523.582

Low:498.297

Close:523.873

Volume:119.87M

Turnover:3.20B

Market Cap:322.68B

Float Cap:286.07B

Loading ...

Great-Sun Foods Posts 250% Surge in Total Profit as Pharmaceutical Arm Begins Consolidation

Cstone Pharma-B Reports Interim Results with Revenue Surging 314.75% to RMB 205 Million

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

CStone Pharmaceuticals - no Dividends Paid, Declared or Proposed During Interim Period

THOMSON REUTERS

CStone 1H FY26 Loss Narrows to RMB 252.28 Million; Revenue Rises to RMB 205.1 Million

CStone Pharmaceuticals H1 Revenue RMB 205.1 Million

THOMSON REUTERS

ZYLOXTB (02190) Spends HK$1.18 Million on Share Buyback on August 27

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Held as Treasury Shares at HKD 21.58-22.06

Healthcare Sector Set for Selective Gains in Second Half, Says Great Wall Fund Manager

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

JW (Cayman) Therapeutics H1 Net Income Attributable RMB -50.4 Million

THOMSON REUTERS

JW (Cayman) Therapeutics - no Dividend Paid or Proposed During Hy

THOMSON REUTERS

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Jinhai Medical Technology H1 Revenue Jumps on China Strength

Recombinant Collagen Leader Faces Growth Challenges After Weak Interim Results

AH Premium Rankings for August 27: A Market Overview

Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces

Akeso Surges Over 6% Intraday as Guosen Securities Initiates 'Outperform' Rating

AI-Driven Drug Discovery Reshaping Scientific Research Paradigms, Long-Term Focus on Continuously Evolving R&D Platforms

When Will CStone Pharmaceuticals (HKG:2616) Breakeven?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1574/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":503.39795,"timestamp":1788163726135,"preClose":523.8731,"halted":0,"volume":119868273,"delay":0,"changeRate":-0.039084,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-20.475159,"latestTime":"08-31 16:00:00","open":523.582,"high":523.582,"low":498.29733,"amount":3203299214.5,"amplitude":0.048265,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"pbRate":3.909696,"peRate":137.956161,"turnoverRate":0.003654,"increases":8,"decrements":24,"flats":1,"marketCap":322680201168,"floatMarketCap":286067329608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":523.582,"amplitude":0.048265,"preClose":523.8731,"low":498.29733,"pbRate":"3.909696","latestPrice":503.39795,"volume":119868273,"delay":0,"open":523.582,"prevYearClose":556.26263,"prevWeekClose":523.873,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.742,"twentyDayClose":467.18,"sixtyDayClose":475.465,"secType":"PLATE","market":"HK","turnoverRate":0.003654,"peRate":137.956161,"marketCap":322680201168,"floatMarketCap":286067329608,"timestamp":1788163726135,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":8,"down":24,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167119384","title":"Great-Sun Foods Posts 250% Surge in Total Profit as Pharmaceutical Arm Begins Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=1167119384","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167119384?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:22","pubTimestamp":1787833347,"startTime":"0","endTime":"0","summary":"Great-Sun Foods Co.,Ltd. (603336.SH) released its 2026 semi-annual report on the evening of August 27. Despite short-term pressure in its core fruit and vegetable business due to industry cycles, the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","BK0238","BK1161","603336","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146657120","title":"Cstone Pharma-B Reports Interim Results with Revenue Surging 314.75% to RMB 205 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1146657120","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146657120?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:42","pubTimestamp":1787830948,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) has released its interim results for the six months ended June 30, 2026, showing a substantial revenue increase of 314.75% to RMB 205 million. The company reported a loss of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662046377","title":"China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662046377","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662046377?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:40","pubTimestamp":1787830849,"startTime":"0","endTime":"0","summary":"China's CStone Pharmaceuticals H1 revenue soars on drug salesOverviewChina biopharma firm's half-year revenue rose 315% yr/yr to RMB205.1 mlnRevenue growth driven by higher pharmaceutical sales, espec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0IS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK0216","688796","LU0502904849.HKD","01801","03692","LU2242644610.SGD","LU2097828474.EUR","HK0000165453.HKD","LU0244354667.USD","LU2097828714.EUR","BK1589","LU1188198961.HKD","LU2097828631.EUR","LU2488822045.USD","BK1574","LU0455707207.USD","LU0463099449.HKD","LU2097828557.USD","BK1161","LU2097828805.USD","LU2328871848.SGD","LU1969619763.USD","LU0326950275.SGD","BK1191","KURE","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662885704","title":"CStone Pharmaceuticals - no Dividends Paid, Declared or Proposed During Interim Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2662885704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662885704?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:34","pubTimestamp":1787830486,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0WN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701081","title":"CStone 1H FY26 Loss Narrows to RMB 252.28 Million; Revenue Rises to RMB 205.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701081","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701081?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:32","pubTimestamp":1787830367,"startTime":"0","endTime":"0","summary":"CStone 1H FY26 loss narrows to RMB 252.28 million; revenue rises to RMB 205.1 millionCStone Pharmaceuticals posted revenue of RMB 205.1 million, more than doubled year over year, driven by higher phar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL1Qdlyp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701706","title":"CStone Pharmaceuticals H1 Revenue RMB 205.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701706?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:32","pubTimestamp":1787830340,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLX88HRFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02616","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138575619","title":"ZYLOXTB (02190) Spends HK$1.18 Million on Share Buyback on August 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1138575619","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138575619?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:59","pubTimestamp":1787828381,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that it repurchased 54,000 of its own shares on August 27, 2026.The transaction, which involved a total outlay of approximately HK$1.1829 million, was conducted as part...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1574","BK1587","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706291","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback Held as Treasury Shares at HKD 21.58-22.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706291","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706291?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:50","pubTimestamp":1787827846,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buyback held as treasury shares at HKD 21.58-22.06Zylox-Tonbridge bought back 54,000 H shares on Aug. 27, holding them as treasury shares","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL9nj6GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1100","BK1587","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101395901","title":"Healthcare Sector Set for Selective Gains in Second Half, Says Great Wall Fund Manager","url":"https://stock-news.laohu8.com/highlight/detail?id=1101395901","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101395901?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:41","pubTimestamp":1787827277,"startTime":"0","endTime":"0","summary":"After a period of correction and consolidation, the healthcare sector has shown robust performance over the past two months, with the once-prominent \"golden track\" seemingly returning to mainstream...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","159992","IBBQ","LNGR","BK1574","BK1515","BK1161","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708043","title":"China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708043","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708043?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:08","pubTimestamp":1787825320,"startTime":"0","endTime":"0","summary":"China's JW Therapeutics interim revenue rises 4.7% on Carteyva salesOverviewChina cell immunotherapy developer's interim revenue grew 4.7% yr/yr, driven by Carteyva salesGross profit margin improved t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU0395794307.EUR","JDOC","AGNG","MEDX","BK1574","LU1934455277.USD","GLAM","LU0859254822.USD","LU0943347566.SGD","LU1188198961.HKD","LU1037948897.HKD","IE000SO60NU8.SGD","IE00BN8TJ469.HKD","LU0463099449.HKD","LU2362541513.USD","03692","FTXH","02126","LU0708994859.HKD","IE0004445239.USD","LU0310799852.SGD","LU0432979614.USD","LU0949170772.SGD","TBXU","VHT","PJP","RXL","IXJ","LU2237443978.SGD","IYH","MADE","KURE","LU1934455863.HKD","XLV","LU2097828714.EUR","IBBQ","IBB","TRUH","LU1244550577.SGD","688331","ABBV","LU0868494617.USD","CMI","01801","PPH","IE00BVYPNV92.GBP","REGN","BBH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708313","title":"JW (Cayman) Therapeutics H1 Net Income Attributable RMB -50.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708313?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:59","pubTimestamp":1787824747,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXX950BC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1161","02126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662083937","title":"JW (Cayman) Therapeutics - no Dividend Paid or Proposed During Hy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662083937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662083937?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:58","pubTimestamp":1787824718,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02126","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708397","title":"JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708397","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708397?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:58","pubTimestamp":1787824692,"startTime":"0","endTime":"0","summary":"JW Cayman Therapeutics FY26 H1 IFRS loss narrows 81.14% to RMB 50.4 million; revenue rises 4.7% to RMB 111.4 millionJW Cayman Therapeutics posted IFRS revenue of RMB 111.4 million, up 4.7% year over y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8Yh1j4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4139","LU2237438978.USD","LU0114720955.EUR","IBB","LU0053666078.USD","LU0109394709.USD","LU0823434740.USD","LU1974910355.USD","LU0889565916.HKD","LU2023250504.SGD","BK1161","LU0823416689.USD","LU1917777945.USD","BK1574","LU0882574055.USD","LU0320765992.SGD","LU0289739699.SGD","LU2362540622.SGD","LU2468319806.SGD","02126","BK4585","IBBQ","LU2106854487.HKD","BBH","LU0823434583.USD","LU2089984988.USD","BK1583","TBXU","LU2362541273.HKD","REGN","LU2362541513.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774250","title":"Jinhai Medical Technology H1 Revenue Jumps on China Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774250","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774250?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:50","pubTimestamp":1787820640,"startTime":"0","endTime":"0","summary":"Jinhai Medical Technology H1 revenue jumps on China strengthOverviewChina-based medical device maker's half-year revenue more than doubled year-over-yearCompany narrowed net loss for the period compar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1150","BK1100","02225","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192894793","title":"Recombinant Collagen Leader Faces Growth Challenges After Weak Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1192894793","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192894793?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:42","pubTimestamp":1787820126,"startTime":"0","endTime":"0","summary":"Jinbo Bio, a leading player in the recombinant collagen sector, recently published its interim report for the first half of 2026, revealing a notable setback in its growth trajectory. The financial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HART","GDOC","BK1583","LNGR","MDEV","LGHT","IEIH","RSPH","MEDX","AGNG","BK1100","PTH","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159208128","title":"AH Premium Rankings for August 27: A Market Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=1159208128","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159208128?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819062,"startTime":"0","endTime":"0","summary":"As of the market close on August 27, the latest A-H share premium data reveals notable movements across dual-listed companies. NE Electric (00042), Zhejiang Shibao (01057), and Holly Futures (03678)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688981","LU0348788117.USD","LU0708995583.HKD","LU0061477393.USD","02691","LU2039709279.SGD","SGXZ81163826.USD","IE0034224299.USD","LU1023057109.AUD","LU0048580855.USD","BK1141","LU0797268264.HKD","BK1533","LU0214875030.USD","03308","03986","LU1255011170.USD","BK1214","LU1481107354.HKD","LU1655091616.SGD","LU2097828557.USD","LU1152091754.HKD","LU0307460666.USD","BK1190","LU0049853897.USD","IE00BF5LJ272.USD","BK1198","LU0072913022.USD","LU0737861772.HKD","IE00B5MMRT66.SGD","03678","LU2177674079.SGD","LU1282649067.USD","BK1574","LU1115378108.SGD","LU0329678337.USD","LU0320764755.SGD","LU0417516902.SGD","LU1282649141.HKD","LU0488056044.USD","LU0516422952.EUR","82846","LU0886674414.USD","EWH","BK1551","LU0828237510.HKD","HK0000320264.USD","01108","BK1507","BK1193","LU1770034418.SGD","IE0008368742.USD","LU2226246903.HKD","00568","01877","LU0314109678.HKD","LU1366334651.USD","LU1064131342.USD","LU1244550221.USD","LU0149534421.HKD","LU0328353924.USD","LU0561508036.HKD","LU0163747925.USD","BK1130","LU0516423174.USD","LU1831875114.USD","BK1522","LU0640798160.USD","LU1242518857.USD","BK1171","LU0359201612.USD","LU1993786604.SGD","01812","LU0039217434.USD","LU0531971595.HKD","LU0572944931.SGD","BK1140","LU0106252389.USD","LU1719994722.HKD","LU0791591158.USD","LU0266512127.USD","BK1202","BK1147","LU0348805143.USD","LU0254981946.USD","LU2294711473.HKD","SG9999004220.SGD","LU0165289439.USD","00187","LU0531970944.HKD","HK0000352291.HKD","LU0228659784.USD","06066","IE0008369823.USD","LU0052750758.USD","02846","LU1794554557.SGD","BK1505","HK0000352382.USD","BK1592","LU0164939612.USD","LU0672654166.SGD","00638","LU0210526637.USD","03759","LU0501845795.SGD","BK1576","LU1807302812.USD","BK1544","LU0231483743.USD","BK1521","LU0516422440.USD","07233","00042","LU0417516738.SGD","LU1064130708.USD","LU1048596156.SGD","06869","LU1251922891.USD","LU1064131003.USD","LU0359202008.SGD","LU0634319403.HKD","LU1282648689.USD","IE00B031HY20.USD","LU2097828805.USD","LU1046422090.SGD","02218","02475","LU1366334578.USD","03328","BK1506","LU0266512473.USD","LU0348767384.USD","LU0588546209.SGD","IE00B0169L03.USD","00553","BK1560","LU1769817096.USD","02827","LU0737861699.HKD","SG9999014674.SGD","BK1607","LU0348814723.USD","LU0589944569.HKD","LU0106959298.USD","LU2097828714.EUR","00300","03296","159982","LU0082770016.USD","HK0000306685.HKD","HK0000320223.HKD","02338","BK1161","LU0228367735.SGD","LU0348825331.USD","LU0431992006.USD","83130","LU1880383440.USD","LU0880133367.SGD","LU0456854461.SGD","LU1813983027.USD","IE00B543WZ88.USD","LU0244354667.USD","LU1769817179.HKD","LU0128522157.USD","LU1688375341.USD","BK1530","BK1144","LU0449509016.USD","LU0067412154.USD","LU2097828474.EUR","LU1961090484.USD","IE00BZ08YS42.EUR","LU2476274720.SGD","LU0329678170.USD","HK0000306701.USD","LU0029875118.USD","IE00BGHQDM52.EUR","LU0918141705.HKD","01033","LU0229945570.USD","SG9999001093.SGD","LU1105468828.SGD","LU2242644610.SGD","LU0509642566.USD","LU0456846285.SGD","LU0149721374.USD","BK1181","BK1515","IE00BYV24P56.USD","BK1546","LU0326950275.SGD","LU0979878070.USD","BK1122","SG9999002463.SGD","LU0181495838.USD","BK1170","BK1163","LU0320764599.SGD","LU1880383366.USD","LU0543330566.HKD","HK0001040143.USD","LU1960683339.HKD","BK1105","BK1554","LU2394011477.USD","BK1149","LU1211504680.USD","09981","83188","LU1188198961.HKD","LU2476274308.USD","LU0345780521.USD","LU1226287529.USD","BK1583","LU0469268626.HKD","LU1988902786.USD","03130","LU0593848301.USD","LU0315179316.USD","LU2399975544.HKD","03143","03750","IE00BVYPNQ40.USD","LU0918141887.USD","BK1562","LU0455707207.USD","LU0140636845.USD","LU0828237940.HKD","IE0031814852.USD","LU0828238088.HKD","LU2125910500.SGD","BK1614","LU0348827113.USD","LU1224709979.USD","BK1526","LU0211977185.USD","LU1242518931.SGD","02768","LU0173614495.USD","BK1594","02359","BK1552","LU1504937902.USD","BK1125","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU0791590937.USD","LU1675838814.USD","00981","03968","BK1110","BK1514","BK1564","LU2008162690.USD","BK1523","SG9999002828.SGD","LU0164865239.USD","LU0345780281.USD","LU1152091168.USD","LU0648948544.HKD","LU0823426308.USD","IE00BMCWC346.EUR","06185","LU0359201885.HKD","LU0269904917.USD","LU1328277881.USD","BK1240","LU0348766576.USD","BK1183","LU0620787316.HKD","LU0890818403.SGD","LU1244550577.SGD","BK0214","LU0117841782.USD","BK1116","LU1303224171.USD","LU0862451753.SGD","IE00B29SXG58.USD","LU0370786039.SGD","LU0821914370.USD","LU0384037296.USD","IE00B031J352.USD","LU1720050803.USD","LU0516423091.SGD","SGXZ49509284.SGD","LU0607220059.USD","01057","BK1231","LU0051755006.USD","BK1237","IE00BVYPNP33.GBP","02899","LU0463099449.HKD","BK1223","LU0543330483.HKD","00895","00811","LU2045819591.USD","LU2148510915.USD","LU2778985437.USD","SG9999006597.SGD","IE00B3M56506.USD","00991","01349","399300","BK1537","HK0001040168.HKD","LU1244550494.USD","LU0868486357.SGD","LU0516422366.SGD","LU0871576103.HKD","BK1209","LU2264538146.SGD","LU0096374516.USD","LU0082770016.SGD","SG9999001226.SGD","LU1282649810.SGD","LU0502904849.HKD","LU0348816934.USD","BK1249","LU1008478684.HKD","01989","BK1191","BK1610","LU2097828631.EUR","LU0823426480.USD","LU0287142896.SGD","SG9999011746.SGD","LU0540923850.HKD","LU0043850808.USD","LU3063872942.SGD","03188","LU1808992512.USD","LU0348735423.USD","LU0327786744.USD","IE0032431581.USD","LU0164880469.USD","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153198003","title":"Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces","url":"https://stock-news.laohu8.com/highlight/detail?id=1153198003","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153198003?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:30","pubTimestamp":1787801432,"startTime":"0","endTime":"0","summary":"As interim earnings reports flood the market, the innovative drug sector has reignited investor enthusiasm, with several leading stocks surging post-results. On August 26, Innovent Biologics jumped...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159316","520880","159992","MEDX","BK1161","BK1574","06978","FLHK","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185413400","title":"Akeso Surges Over 6% Intraday as Guosen Securities Initiates 'Outperform' Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1185413400","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185413400?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:01","pubTimestamp":1787799711,"startTime":"0","endTime":"0","summary":"Akeso (09926) climbed more than 6% during Wednesday's trading session before paring gains, last up 2.34% at HK$96.40 with turnover reaching HK$686 million.On August 26, Akeso announced that its phase...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348735423.USD","LU0348783233.USD","LU0417516738.SGD","LU0348825331.USD","LU0348766576.USD","LU0417516902.SGD","LU2778985437.USD","IE00BPRC5H50.USD","LU0561508036.HKD","002736","LU0348784397.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","BK1574","LU0634319403.HKD","LU2399975544.HKD","LU1794554557.SGD","09926","LU1961090484.USD","LU1720050803.USD","LU2476274308.USD","LU2488822045.USD","LU2476274720.SGD","BK0028","BK0188","BK0183","KURE","LU0348827113.USD","LU0348767384.USD","IE00B543WZ88.USD","LU0540923850.HKD","BK1161","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134623279","title":"AI-Driven Drug Discovery Reshaping Scientific Research Paradigms, Long-Term Focus on Continuously Evolving R&D Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=1134623279","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134623279?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:04","pubTimestamp":1787796269,"startTime":"0","endTime":"0","summary":"Zheshang Securities has released a research report indicating that the pharmaceutical R&D industry is undergoing a similar industrial transformation: the number of biochemical large models is growing...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","ARTY","BK1191","AIPO","BK0276","AGIX","QTOC","BK1574","01477","CHAT","601878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720848","title":"When Will CStone Pharmaceuticals (HKG:2616) Breakeven?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720848","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720848?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:24","pubTimestamp":1787793884,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at CStone Pharmaceuticals...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/when-will-cstone-pharmaceuticals-hkg2616-breakeven-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/when-will-cstone-pharmaceuticals-hkg2616-breakeven-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":6,"totalSize":377,"code":"91000000","status":"200"}]}}